MolecularHealth Boosts Advisory Board

The Woodlands-based MolecularHealth, which is developing an automated, genetic testing platform for cancer, said today that it has added three members to its advisory board. According to the company, it has added Joyce O'Shaughnessy, M.D. (US Oncology, National Cancer Institute); Burton M. Schwartz, M.D., (Minnesots Oncology, US Oncology); and THomas M. Wheeler, M.D. (Baylor College of Medicine) to its advisory board. All three are involved in oncology and pathology. MolecularHealth is led by Lloyd Everson, M.D.